Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Inspiremd Inc (NSPR)

Inspiremd Inc (NSPR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,522
  • Shares Outstanding, K 4,339
  • Annual Sales, $ 3,720 K
  • Annual Income, $ -10,040 K
  • 60-Month Beta 1.92
  • Price/Sales 0.70
  • Price/Cash Flow N/A
  • Price/Book 0.41
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -7.24
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/12/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.60
  • Number of Estimates 1
  • High Estimate -0.60
  • Low Estimate -0.60
  • Prior Year -3.82
  • Growth Rate Est. (year over year) +84.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4800 +21.10%
on 03/16/20
1.0300 -43.56%
on 03/05/20
-0.3901 (-40.16%)
since 03/03/20
3-Month
0.4800 +21.10%
on 03/16/20
1.6400 -64.55%
on 01/17/20
-0.4887 (-45.67%)
since 01/03/20
52-Week
0.4800 +21.10%
on 03/16/20
7.5100 -92.26%
on 05/02/19
-6.5587 (-91.86%)
since 04/03/19

Most Recent Stories

More News
InspireMD to Report Fourth Quarter 2019 Financial Results and Provide Business Update on Tuesday, March 10

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today that it will host a conference...

NSPR : 0.5813 (-3.28%)
InspireMD Announces Successful Live Clinical Case Transmissions Featuring CGuard(TM) EPS at the Leipzig Interventional Course (LINC) 2020

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today announced that a successful live...

NSPR : 0.5813 (-3.28%)
InspireMD's CGuard(TM) Embolic Prevention System to be Prominently Featured in Live Case Transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany

InspireMD, Inc. (NYSE American: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that its CGuard(TM) Carotid Embolic Prevention...

NSPR : 0.5813 (-3.28%)
DexCom (DXCM) Hits Fresh High: Is There Still Room to Run?

DexCom (DXCM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

DXCM : 260.75 (-2.11%)
HOLX : 32.82 (-3.64%)
NSPR : 0.5813 (-3.28%)
STE : 138.72 (-0.59%)
InspireMD Announces Strong Preliminary Fourth Quarter 2019 Revenue and Reports Inducement Award Under NYSE American Company Guide §711(a)

InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced strong preliminary...

NSPR : 0.5813 (-3.28%)
Zacks.com featured highlights include: Civeo, InspireMD, Westport Fuel Systems, Genesco and Radware

Zacks.com featured highlights include: Civeo, InspireMD, Westport Fuel Systems, Genesco and Radware

RDWR : 20.67 (+0.88%)
WPRT : 0.7810 (-7.05%)
CVEO : 0.3732 (-5.76%)
NSPR : 0.5813 (-3.28%)
GCO : 10.40 (-3.35%)
5 Stocks With Rising P/E That Won't Let You Down

Bet on these top-ranked stocks with rising P/E to realize outsized gains.

RDWR : 20.67 (+0.88%)
WPRT : 0.7810 (-7.05%)
CVEO : 0.3732 (-5.76%)
NSPR : 0.5813 (-3.28%)
GCO : 10.40 (-3.35%)
InspireMD to Report Third Quarter 2019 Financial Results and Provide Business Update on Tuesday, November 12

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it...

NSPR : 0.5813 (-3.28%)
InspireMD, Inc. Announces Pricing of $5 Million Underwritten Public Offering

InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today announced the pricing of an underwritten...

NSPR : 0.5813 (-3.28%)
InspireMD Provides Business Update

InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today provided a business update.

NSPR : 0.5813 (-3.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NSPR with:

Business Summary

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous...

See More

Key Turning Points

2nd Resistance Point 0.6224
1st Resistance Point 0.6019
Last Price 0.5813
1st Support Level 0.5589
2nd Support Level 0.5364

See More

52-Week High 7.5100
Fibonacci 61.8% 4.8245
Fibonacci 50% 3.9950
Fibonacci 38.2% 3.1655
Last Price 0.5813
52-Week Low 0.4800

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar